SCHEMBL771673

SCHEMBL771673

CCOC(=O)c1cnn(CC2CC2)c1-c1ccncc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
ALDH1A1 P00352 2/20 0.48
CDC7 O00311 6/20 0.45
DBF4 Q9UBU7 5/20 0.45
CASP1 P29466 1/20 0.43
MAPK1 P28482 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.42
CSNK1D P48730 1/20 0.42
S1PR1 P21453 1/20 0.42
DYRK1A Q13627 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
HPGD P15428 1/20 0.40
CLK1 P49759 1/20 0.40
UBE2N P61088 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ROCK2 O75116 1/20 0.40
PIM1 P11309 1/20 0.40
GSK3B P49841 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL773601 0.81 ALDH1A1 (0.50) LMNAALDH1A1CDC7DBF4CASP1
SCHEMBL772322 0.81 ALDH1A1 (0.50) LMNAALDH1A1CDC7DBF4CASP1
SCHEMBL774907 0.78 LMNA (0.47) LMNAALDH1A1CDC7DBF4CASP1
SCHEMBL31352353 0.78 LMNA (0.88) LMNAALDH1A1NPC1HPGDHSD17B10
SCHEMBL772745 0.77 ALDH1A1 (0.55) LMNAALDH1A1CDC7DBF4MAPK1
SCHEMBL15750636 0.77 ALDH1A1 (0.53) ALDH1A1CDC7DBF4CASP1MAPK1
SCHEMBL1406947 0.75 LMNA (0.60) LMNAALDH1A1CASP1NPC1HPGD
SCHEMBL31352264 0.73 LMNA (0.93) LMNAALDH1A1NPC1HPGDHSD17B10
SCHEMBL31352281 0.73 LMNA (0.97) LMNAALDH1A1NPC1CSNK1DHPGD
SCHEMBL16212583 0.72 LMNA (0.60) LMNAALDH1A1NPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
WO-2010142628-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO S.A. (CH) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS S1PR1, S1PR3, S1PR2 LMNA 4315/4885ALDH1A1 1615/4885CDC7 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.